Hero Image

Devices for Diabetes Management - 2026 Buyer’s Guide

Diabetes tech has evolved from simple fingerstick meters to a connected ecosystem that can predict, prevent, and smooth out highs and lows.

Whether you live with type 1 or type 2 diabetes, understanding the core devices for diabetes management—and what’s new now—helps you choose tools that fit your routine, budget, and goals.

Essential devices you’ll use daily

Blood glucose meters (BGMs). Still vital for many, BGMs provide point-in-time readings from a fingerstick. Look for meters that meet accuracy standards, have affordable strips, and sync to your phone. For background on performance and labeling, see the U.S. Food and Drug Administration’s overview of over-the-counter blood glucose monitoring systems. Even if you use a CGM, a BGM is helpful for calibrations (some systems) and as a backup.

Continuous glucose monitors (CGMs). CGMs use a tiny sensor under the skin to measure glucose every few minutes and send readings to a phone or receiver. Benefits include trend arrows, alerts, and time-in-range tracking, which the American Diabetes Association (ADA) highlights for day-to-day decision-making. Leading options include Dexcom G7 and FreeStyle Libre 3 (both “iCGM”-designated for interoperability), as well as the implantable Eversense E3 with a 6‑month sensor. CGMs reduce hypoglycemia, support exercise and meal planning, and make remote sharing with loved ones or clinicians easy.

Insulin pens and smart pens. For those on multiple daily injections, smart pens and caps log dosing and timing automatically, helping prevent missed or stacked doses. Options include Medtronic InPen and the Bigfoot Unity smart cap system that works with compatible disposable pens and provides dose guidance based on glucose readings.

Insulin pumps. Pumps deliver rapid-acting insulin continuously (basal) with on-demand meal doses (bolus). Tubed pumps like Tandem t:slim X2 with Control‑IQ and Medtronic MiniMed 780G and tubeless patch pumps like Omnipod 5 can pair with select CGMs to automate parts of insulin delivery.

New and noteworthy tech (what’s emerging now)

Smaller, smarter insulin pumps

Tandem Mobi. The ultra-compact Mobi is designed to be worn discreetly and controlled from a smartphone, building on the company’s automated features. Learn more at Tandem Diabetes.

Omnipod 5 advances. Omnipod’s tubeless platform continues to refine automated algorithms and integrations to improve time-in-range without tubing.

Automated insulin delivery (AID) that adapts to you

Hybrid closed-loop systems use CGM data and algorithms to adjust basal insulin automatically and often recommend correction boluses. Options include MiniMed 780G, Omnipod 5, and Control‑IQ-enabled setups. The iLet Bionic Pancreas from Beta Bionics aims to further simplify setup by starting with body weight and learning from your data instead of requiring extensive carb ratios.

Expect continued progress in “interoperable” components—iCGM sensors, ACE pumps, and controller apps—that the FDA has been encouraging to give users more mix‑and‑match choice. See the FDA’s page on integrated CGM (iCGM) systems.

CGM evolution: thinner, easier, longer wear

Newer CGMs emphasize quicker warm‑up times, slimmer on‑body profiles, and improved Bluetooth connectivity. Devices like Dexcom G7 and Libre 3 focus on seamless phone and smartwatch viewing, tighter integration with AID systems, and factory calibration. The long‑wear Eversense E3 caters to those who prefer infrequent sensor changes.

Data platforms and coaching that lighten the load

Connected apps consolidate data, identify patterns, and can share summarized insights with your care team. Popular options include Glooko, nonprofit Tidepool, and the open‑source community around Nightscout. FDA‑cleared Tidepool Loop also opened the door to interoperable AID controllers on iPhone, signaling a future of more flexible, software‑driven therapy.

Emergency preparedness: modern glucagon

Ready‑to‑use glucagon has largely replaced older kits that required mixing. Options include nasal Baqsimi and autoinjectors like Gvoke HypoPen and Zegalogue. Keep one at home, work, and in your bag if you use insulin or have a history of severe lows.

Ketone testing gets more connected

During illness or persistent highs, ketone checks help you detect and prevent diabetic ketoacidosis (DKA). Blood ketone meters such as Abbott’s Precision Xtra pair with test strips to quantify beta‑hydroxybutyrate; see the CDC’s primer on DKA warning signs. Some meters and apps now log readings alongside glucose for a fuller picture during sick days.

How to choose the right setup

Use this quick framework to narrow your options and build a device mix that serves your goals.

  • Your therapy: If you take insulin multiple times daily, a CGM is strongly recommended and may be covered by insurance; pumps or AID systems can reduce time spent high or low.
  • Lifestyle fit: Prefer injections? A smart pen plus CGM can be low‑profile and powerful. Hate tubing? Consider a tubeless pump.
  • Budget and coverage: Factor in sensors, strips, pods, infusion sets, and app subscriptions. Many manufacturers offer savings programs.
  • Data needs: If you love metrics, choose devices with robust mobile apps, alerts you can fine‑tune, and easy clinician sharing.
  • Comfort and maintenance: Consider wear locations, change frequency, and adhesive preferences. Ask for sample wear patches when possible.

Costs, coverage, and prescriptions

Device coverage varies widely by country and plan. In the U.S., Medicare and many private insurers cover CGMs for people using insulin, with criteria that have broadened in recent years. See CMS’s fact sheet on Medicare coverage for CGMs. Pumps, AID systems, and smart pens typically require prescriptions and prior authorizations; a diabetes educator or pharmacist can help navigate options and training.

Safety, accuracy, and privacy

Accuracy: Modern CGMs and meters perform well when used as directed, but hydration, compression, and sensor age can affect readings. Confirm with a fingerstick if symptoms don’t match your CGM.

Alerts and automation: Set high/low alerts conservatively at first and refine over time. Automation helps but still relies on accurate carb counts, site quality, and timely sensor changes.

Data privacy: Review app permissions and sharing settings. If you export data to third‑party apps, understand how it’s stored and who can access it.

Quick starter kits by goal

  • Keep it simple: Accurate BGM + CGM for trends + ready‑to‑use glucagon.
  • Automation first: AID system (compatible pump + CGM) + carb entry + backup BGM.
  • Injections, zero tubing: Smart pen/cap system + CGM + ketone meter for sick days.
  • Data power user: CGM + interoperable pump + app ecosystem (e.g., Tidepool or Glooko) for deep pattern analysis.

Key takeaways

  • Start with the essentials: a reliable glucose monitor (BGM or, ideally, a CGM) and an insulin delivery method that matches your lifestyle.
  • Today’s diabetes management devices increasingly connect and automate—AID systems, smart pens, and streamlined CGMs reduce daily burden.
  • New tech focuses on size, simplicity, and interoperability. Verify coverage and training support before switching.
  • Work with your diabetes care team to tailor settings, interpret data, and stay safe during illness, travel, and exercise.

If you’re choosing your first setup or planning an upgrade, make a short list of must‑haves (comfort, discretion, automation, costs), bring it to your next appointment, and ask to trial demo gear before you commit.